-
3:00 PM – 4:00 PMP01 – Department of Corrections: Bringing It To The MAT
Angela Bonaguidi, LCSW, LAC, MAC, MSWCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP02 – Effectively Reducing Stigma and increasing access to care in the Community.
Allie V. Severino – Fresh Start InitiativeCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP03 – Improving the Continuum of Care: Overview of a Peer-Operated Warm Line to Address the Opioid Epidemic
Dawn Farrell-Moore, LCSW – Richmond Behavioral Health Authority; Lauren Stevens, LCSW – Richmond Behavioral Health Authority; Neal Masri, Ph.D. – Richmond Behavioral Health AuthorityCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP04 – Michigan Re-Entry Project: Wraparound Services and Medication Assisted Treatment for Returning Citizens
Emily Pasman, LLMSW – Wayne State University Center for Behavioral Health and JusticeCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP05 – Pharmacists Taking Action: Screening Patients for Opioid Misuse and Accidental Overdose Within Community Pharmacies
Heidi Eukel, PharmD – North Dakota State UniversityCommunity Partners & Continuum of Care
-
3:00 PM – 4:00 PMP07 – Changes in the Prevalence of Methamphetamine Abuse among Individuals Entering Medication-Assisted Treatment Programs
Karin McBride, M.A. – Denver Health, Rocky Mountain Poison & Drug Center – RADARS® System; S. Geoff Severtson, PhD – Denver Health, Rocky Mountain Poison & Drug Center – RADARS SystemOpioid Abuse as a Public Health Crisis and Overdose as an Epidemic
-
3:00 PM – 4:00 PMP08 – Collaboration between Public Health and MAT in the Treatment of Hepatitis C
Jacqueline Martin, MS in Psychology Evaluation, Research, and Measurement; Brian Goodlett, MA – New Mexico Treatment ServicesOpioid Abuse as a Public Health Crisis and Overdose as an Epidemic
-
3:00 PM – 4:00 PMP10 – Opioid Use, Prior Substance Use Treatment, and Age at First Use: Clients Discharged at a NYC Treatment Provider in 2018
Olivia Charles, MPH – Samaritan Daytop VillageOpioid Abuse as a Public Health Crisis and Overdose as an Epidemic
-
3:00 PM – 4:00 PMP12 – Atomoxetine and Methylphenidate in the treatment of cocaine use disorder in heroin use disorder patients with concomitant adult ADHD
Giada CipollonePatient Care & Best Practices
-
3:00 PM – 4:00 PMP13 – Awareness and willingness for uptake of Pre-exposure prophylaxis among people who use drugs (PWUD) in Ngara Methadone Clinic (MAT) Nairobi, Kenya
Brenda Mogaka, Dr – Nairobi City County Methadone ClinicPatient Care & Best Practices
-
3:00 PM – 4:00 PMP14 – Emerging from the shadows: Hearing the Patient Voice
Sonya J. Lockyer, MBA – Canadian Addiction Treatment Centres; Kate Johnston, BA – Canadian Addiction Treatment Centres; David C. Marsh, MD – Canadian Addiction Treatment CentresPatient Care & Best Practices
-
3:00 PM – 4:00 PMP15 – Further evidence of a psychopathology specific to heroin use disorder. Psychopathological dimensions and addictive behaviours: relationships
Filippo Della Rocca, Resident in Psychiatry – University of Pisa, Clinica psichiatrica Santa ChiaraPatient Care & Best Practices
-
3:00 PM – 4:00 PMP16 – Getting to Stable: Do Early Peak Dose Evaluations Enhance Patient Stability?
James E. Anderson, PA-C – Evergreen Treatment ServicesPatient Care & Best Practices
-
3:00 PM – 4:00 PMP17 – Impact of Co-morbid Cocaine Use on Maternal and Infant Outcomes among Pregnant Women Receiving Medication Assisted Treatment
Mellissa Giegerich, BS (MSW research assistant); Michelle Tuten, PhDPatient Care & Best Practices
-
3:00 PM – 4:00 PMP18 – Improving Engagement and Retention by Initiating Treatment with Methadone for Opioid Use Disorder in an Inpatient Rehabilitation Setting
Gloria Baciewicz, MD – Strong RecoveryPatient Care & Best Practices
-
3:00 PM – 4:00 PMP19 – Occupational Therapy Treatment Techniques used Concurrently with MAT for the Management of Pain Associated with OUD
Pat Precin, PhD, PsyaD. OTR/L, LP, NCPsyA – Columbia UniversityPatient Care & Best Practices
-
3:00 PM – 4:00 PMP20 – Practical Tools for Treating Opioid Use Disorders among Individuals in Custody
Niki A. Miller, MS, CPS – Advocates for Human Potential, Inc.; Andrew Klein, PhD – Advocates for Human Potential, Inc.Patient Care & Best Practices
-
3:00 PM – 4:00 PMP21 – Reasons for starting and stopping medications for opioid use disorder: a qualitative analysis
Barbara Andraka-Christou, J.D., PhD – University of Central FloridaPatient Care & Best Practices
-
3:00 PM – 4:00 PMP22 – Same Day Access to Buprenorphine for Veterans with Opioid Use Disorders
Sara Chaudhry, LICSW – VA Puget Sound Health Care System; Sergio Flores, PsyD – VA Puget Sound Health Care System; Tory A. Durham, PhD – VA Puget Sound, SeattlePatient Care & Best Practices
-
3:00 PM – 4:00 PMP23 – Successfully Engaging People with Substance Dependence and Hepatitis and/or Human Immunodeficiency Virus into Medical Treatment.
Despina Vougioukas, CRC – Lower Eastside Service Center; Joe Krasnansky, LCSW-R – Lower Eastside Service CenterPatient Care & Best Practices
-
3:00 PM – 4:00 PMP24 – Integrating the Community Pharmacist in Upstream Prevention of Opioid Misuse and Accidental Overdose
Amy Werremeyer, PharmD – North Dakota State University; Heidi Eukel, PharmD – North Dakota State UniversityWorkforce Development
-
3:00 PM – 4:00 PMP25 – Linguistic Bias and Stigma Among Individuals in Substance Use Disorder Recovery and the Health Professionals Who Treat Them
Robert D. Ashford, MSW – Substance Use Disorders Institute, University of the sciences; Gail G. Scott, MPH – University of the Sciences; Andrew Peterson, PharmD PhD – Substance Use Disorders Institute, University of the SciencesWorkforce Development
Available Pages
- #10171 (no title)
- #Blacklivesmatter
- 2016 Awards Program
- 2016 Conference Photos
- 2022 Conference Albums
- AATOD Conference
- AATOD Homepage
- AATOD Homepage – Testing Page Only
- AATOD’s Project Update: Opioid Use Study
- About Baltimore
- About Us
- Activity
- Advocacy
- Board Member Login Area
- Brenda Davis, MSW
- Brief Historical Background
- CMS-1770-P
- Conclusion
- Conference Center
- Conference Development/Training
- Conference Newsletter – Edition No. 6
- Conference Opening October 19 – 20, 2019
- Connecticut’s Mobile Medication Assisted Treatment
- Connecting Justice with Treatment – Part 1
- COVID-19
- Criminal Justice
- Developing Educational Initiatives for Members of Congress
- Dispensing Methadone Through Pharmacies
- Expanding the Footprint of OTPs in United States
- Expanding the Footprint of OTPs in United States
- Five – Year Plan (2022 – 2026)
- Forum
- Funding
- Funding
- Gail G. Scott, MPH
- Give
- In Memoriam of Kate Mahoney
- Increased Access to Interim Care through an OTP
- Increasing the Number of OTPs and Patients in the United States
- Indiana Community Mental Health Center
- Individual Membership File Sharing Area
- International Work
- Introduction
- Introduction
- Media
- Members
- Missouri’s Effort to Expand Accèss to MAT to Incarcerated
- Misty Challinor
- Mobile Vans
- Mobile Vans
- Moving Forward with Innovative Change
- New Jersey Passes Law
- New York State Advocates Seek Legislation
- Non-Mobile Van Units
- Opioid Education
- Passing of the Baton…Baltimore 2022
- Press Release – April 22, 2021
- Press Release, HHS / SAMHSA Releases New OTP Regulations
- Prologue
- Ray Caesar, LPC
- Recommendations
- Recommended Changes in Federal and State Oversight for OTPs
- References
- Regulatory Reform
- Rhode Island Model of MOUD in Corrections Withstands COVID…
- Robert Kent
- Robert Lambert, MA
- Satellite Medication Units
- Support
- Telehealth Services Through OTPs
- Telehealth Services Through OTPs
- The Combined COVID-19 Pandemic and Opioid Use
- The Combined COVID-19 Pandemic and Opioid Use Epidemic
- The Impact of COVID-19 on OTPs
- Walter Ginter, CMA
- Washington State Prescription Monitoring Program
- Webinar Development, Enhanced Communication
- Welcome to AATOD’s 2021 Virtual Conference
- Workforce Shortages and Development
- Working with Denver Health and Hospital Authority/RADARS® System
- Membership Categories & Benefits
- Members Only